ABIVAX: Share Capital and Voting Rights as of April 30, 2026

On May 29, 2026, ABIVAX announced the number of shares and voting rights as of April 30, 2026. The company's share capital is €797,299.91, divided into 79,308,916 shares. Theoretical voting rights amount to 81,658,865, including shares without voting rights. Exercisable voting rights also total 81,658,865, including shares without voting rights. These figures are disclosed in accordance with Article L. 233-8 II of the French Commercial Code and Article 223-16 of the AMF (French Financial Markets Authority) regulations. ABIVAX, listed on Euronext Paris, thus provides essential transparency for its investors and the financial market.